IG Pharma Compliance Guide Has First Amendment Flaws, Attorney Says
Executive Summary
The HHS Inspector General's pharmaceutical compliance guide may be the next battleground for First Amendment cases, Wiley, Rein & Fielding Attorney John Kamp said at an OIG compliance guide symposium in Princeton, N.J. July 23
You may also be interested in...
Neurontin Ruling Is Guide For DoJ Off-Label Promotion Cases – Prosecutor
A recent ruling in the Neurontin "whistleblower" case lays the groundwork for future prosecutions involving off-label promotions under the False Claims Act, Philadelphia Assistant U.S. Attorney Virginia Gibson said Oct. 2 during an audioconference sponsored by the Pharmaceutical Compliance Forum
Neurontin Ruling Is Guide For DoJ Off-Label Promotion Cases – Prosecutor
A recent ruling in the Neurontin "whistleblower" case lays the groundwork for future prosecutions involving off-label promotions under the False Claims Act, Philadelphia Assistant U.S. Attorney Virginia Gibson said Oct. 2 during an audioconference sponsored by the Pharmaceutical Compliance Forum
Medco Reports New Problems With Mail-Order Recordkeeping
Medco is conducting an internal audit of its mail order prescription turnaround times to ensure that performance reports given to clients are accurate